TEOSYAL referencias disponibles en ALLPARA para uso profesional, de origen directo y certificadas en cada envío.
Teosyal RHA 3
TEOSYAL RHA 3 is a transparent, sterile, non-pyrogenic and viscoelastic hyaluronic acid filler of non-animal origin from Teoxane SA in Geneva, designed to correct deep facial wrinkles and deep skin creases. It is also indicated to add volume in the midface and to remodel the lower face. The product contains 23 mg/mL of hyaluronic acid, cross-linked with BDDE at a mean molecular weight above 1 million Dalton, and 0.3% by mass of lidocaine hydrochloride. Each box contains two 1 mL pre-filled syringes, every one with two sterile 27G 1/2 inch needles and two traceability labels.
Principales ventajas de Teosyal RHA 3
- Corrects deep facial wrinkles and deep skin creases
- Adds volume in the midface and remodels the lower face
- Also indicated for the perioral region, including the lips
- Hyaluronic acid at 23 mg/mL with a degree of cross-linking below 5%
- Mean molecular weight above 1 million Dalton, of non-animal origin, residual BDDE below 1 ppm
- Contains lidocaine hydrochloride 0.3% by mass to reduce the sensation of pain
- Two pre-filled 1 mL syringes per box, each with two sterile 27G 1/2 inch needles
- Estimated duration of 12 to 18 months
Indicaciones y uso profesional
Indicaciones principales
- Correction of any deep facial wrinkles and deep skin creases
- Adding volume in the midface
- Remodelling of the lower face
- Therapeutic indications: reconstructive surgery, filling of depressions due to scars, and reconstruction of volumes lost by lipoatrophy in patients undergoing HIV treatment
Uso profesional
TEOSYAL RHA 3 is only to be administered by appropriately trained healthcare professionals who are qualified or accredited in accordance with national law, and is not for retail sale or self-administration. It is injected slowly at variable depths depending on the area treated: into the dermis, subcutaneously, onto the supraperiosteum, or into the subdermis or the submucosa of the red lips. Where a cannula is used, an entry point is made in the skin with a sharp needle of appropriate size. It must not be injected into the epidermis, into or close to a blood vessel, close to a nerve, or at depths other than those described. Depending on the correction required, one or more treatment sessions or a touch-up may be needed.
Zonas de tratamiento
- Midface: nasolabial folds, cheeks, nasojugal groove
- Lower face: chin, jawline
- Perioral region: lips including the philtrum, marionette lines, oral commissures
Perfil del paciente
For adults assessed as suitable by the treating practitioner, typically those with deep creases or midface volume loss rather than fine surface lines. It must not be used in patients with cutaneous disorders, inflammation or infection at or near the treatment site, since injection procedures can lead to reactivation of latent or subclinical herpes viral infection. It must also not be used in patients with a known hypersensitivity to hyaluronic acid with a history of severe allergy or anaphylactic shock, in patients with autoimmune diseases, or in pregnant or breastfeeding women. Because of the lidocaine content it must not be used in patients with known hypersensitivity to lidocaine or to amide local anaesthetics, in patients with cardiac diseases or undergoing treatment for heart disease (beta blockers), in patients with hepatocellular insufficiency or undergoing treatment for a liver disease, or in patients with epilepsy or porphyria. It must not be used in combination with other aesthetic procedures such as peeling, laser treatment or ultrasound-based treatment.
Cómo funciona Teosyal RHA 3
TEOSYAL RHA 3 works through hyaluronic acid at 23 mg/mL with a degree of cross-linking below 5%, delivered through a wider 27G needle than RHA 1 and RHA 2. Hyaluronic acid binds water and restores volume where tissue has been lost, which is what allows this grade to fill a deep crease and rebuild midface volume.
Por qué comprar en Allpara
Allpara ofrece productos TEOSYAL originales y verificados de proveedores seleccionados, con trazabilidad completa de lotes y asesoramiento experto. Atendemos a clínicas y profesionales de la estética con productos con certificado CE, entrega rápida en toda la UE desde nuestro almacén en la UE y precios profesionales competitivos. Nuestra prioridad es la seguridad, la satisfacción y los resultados de sus pacientes, con un servicio posventa dedicado para su tranquilidad.
Preguntas frecuentes
How does TEOSYAL RHA 3 differ from RHA 2 and RHA 4?
All three carry 23 mg/mL hyaluronic acid with cross-linking below 5%. RHA 2 is for facial wrinkles and creases across four regions, in a 1 ml syringe with 30G needles. RHA 3 is for deep wrinkles and midface volume, also in a 1 ml syringe but with 27G needles. RHA 4 is for facial contour remodelling in thick skin areas, in a 1.2 ml syringe with 27G needles, and lasts 15 to 18 months rather than 12 to 18.
How long does TEOSYAL RHA 3 last?
The estimated in vivo lifetime is 12 to 18 months. Duration depends on skin type, the severity of the wrinkle treated, the injection area, the volume injected, and the patient's physiology and lifestyle.
Más productos de Teoxane
TEOXANE referencias disponibles en ALLPARA para uso profesional, de origen directo y certificadas en cada envío.
TEOXANE Productos
Ver todo 18Alternativas para la clínica
Retome donde lo dejó
Teosyal RHA 3
TEOSYAL RHA 3 is a transparent, sterile, non-pyrogenic and viscoelastic hyaluronic acid filler of non-animal origin from Teoxane SA in Geneva, designed to correct deep facial wrinkles and deep skin creases. It is also indicated to add volume in the midface and to remodel the lower face. The product contains 23 mg/mL of hyaluronic acid, cross-linked with BDDE at a mean molecular weight above 1 million Dalton, and 0.3% by mass of lidocaine hydrochloride. Each box contains two 1 mL pre-filled syringes, every one with two sterile 27G 1/2 inch needles and two traceability labels.
Principales ventajas de Teosyal RHA 3
- Corrects deep facial wrinkles and deep skin creases
- Adds volume in the midface and remodels the lower face
- Also indicated for the perioral region, including the lips
- Hyaluronic acid at 23 mg/mL with a degree of cross-linking below 5%
- Mean molecular weight above 1 million Dalton, of non-animal origin, residual BDDE below 1 ppm
- Contains lidocaine hydrochloride 0.3% by mass to reduce the sensation of pain
- Two pre-filled 1 mL syringes per box, each with two sterile 27G 1/2 inch needles
- Estimated duration of 12 to 18 months
Indicaciones y uso profesional
Indicaciones principales
- Correction of any deep facial wrinkles and deep skin creases
- Adding volume in the midface
- Remodelling of the lower face
- Therapeutic indications: reconstructive surgery, filling of depressions due to scars, and reconstruction of volumes lost by lipoatrophy in patients undergoing HIV treatment
Uso profesional
TEOSYAL RHA 3 is only to be administered by appropriately trained healthcare professionals who are qualified or accredited in accordance with national law, and is not for retail sale or self-administration. It is injected slowly at variable depths depending on the area treated: into the dermis, subcutaneously, onto the supraperiosteum, or into the subdermis or the submucosa of the red lips. Where a cannula is used, an entry point is made in the skin with a sharp needle of appropriate size. It must not be injected into the epidermis, into or close to a blood vessel, close to a nerve, or at depths other than those described. Depending on the correction required, one or more treatment sessions or a touch-up may be needed.
Zonas de tratamiento
- Midface: nasolabial folds, cheeks, nasojugal groove
- Lower face: chin, jawline
- Perioral region: lips including the philtrum, marionette lines, oral commissures
Perfil del paciente
For adults assessed as suitable by the treating practitioner, typically those with deep creases or midface volume loss rather than fine surface lines. It must not be used in patients with cutaneous disorders, inflammation or infection at or near the treatment site, since injection procedures can lead to reactivation of latent or subclinical herpes viral infection. It must also not be used in patients with a known hypersensitivity to hyaluronic acid with a history of severe allergy or anaphylactic shock, in patients with autoimmune diseases, or in pregnant or breastfeeding women. Because of the lidocaine content it must not be used in patients with known hypersensitivity to lidocaine or to amide local anaesthetics, in patients with cardiac diseases or undergoing treatment for heart disease (beta blockers), in patients with hepatocellular insufficiency or undergoing treatment for a liver disease, or in patients with epilepsy or porphyria. It must not be used in combination with other aesthetic procedures such as peeling, laser treatment or ultrasound-based treatment.
Cómo funciona Teosyal RHA 3
TEOSYAL RHA 3 works through hyaluronic acid at 23 mg/mL with a degree of cross-linking below 5%, delivered through a wider 27G needle than RHA 1 and RHA 2. Hyaluronic acid binds water and restores volume where tissue has been lost, which is what allows this grade to fill a deep crease and rebuild midface volume.
Por qué comprar en Allpara
Allpara ofrece productos TEOSYAL originales y verificados, con trazabilidad completa de lotes, stock con certificado CE, entrega rápida en toda la UE y servicio posventa experto.
Preguntas frecuentes
How does TEOSYAL RHA 3 differ from RHA 2 and RHA 4?
All three carry 23 mg/mL hyaluronic acid with cross-linking below 5%. RHA 2 is for facial wrinkles and creases across four regions, in a 1 ml syringe with 30G needles. RHA 3 is for deep wrinkles and midface volume, also in a 1 ml syringe but with 27G needles. RHA 4 is for facial contour remodelling in thick skin areas, in a 1.2 ml syringe with 27G needles, and lasts 15 to 18 months rather than 12 to 18.
How long does TEOSYAL RHA 3 last?
The estimated in vivo lifetime is 12 to 18 months. Duration depends on skin type, the severity of the wrinkle treated, the injection area, the volume injected, and the patient's physiology and lifestyle.